Outcome of Sarcoidosis

Siltzbach, 1967, Sarcoidosis: clinical features and management, Med Clin North Am, 51, 483, 10.1016/S0025-7125(16)33069-3 1999, American Thoracic Society (ATS), The European Respiratory Society (ERS), and the World Association of sarcoidosis and other granulomatous disorders (WASOG). Statement of sarcoidosis, Am J Respir Crit Care Med, 160, 736 Nagai, 1999, Clinical courses and prognoses of pulmonary sarcoidosis, Curr Opin Pulm Med, 5, 293, 10.1097/00063198-199909000-00005 Mana, 1999, Lofgren's syndrome revisited: a study of 186 patients, Am J Med, 107, 240, 10.1016/S0002-9343(99)00223-5 Baughman, 2006, Presenting characteristics as predictors of duration of treatment in sarcoidosis, Q J Med, 99, 307, 10.1093/qjmed/hcl038 Turner-Warwick, 1988, Treatment of pulmonary sarcoidosis. State of the art, 621 Lynch, 1997, Pulmonary sarcoidosis, Clin Chest Med, 18, 755, 10.1016/S0272-5231(05)70417-2 Shah, 2007, Lung transplantation in sarcoidosis, Semin Respir Crit Care Med, 28, 134, 10.1055/s-2007-970339 Katz, 1983, Clinical presentation and natural history of sarcoidosis, 3 Hunninghake, 1994, Outcome of the treatment for sarcoidosis, Am J Respir Crit Care Med, 149, 893, 10.1164/ajrccm.149.4.8143052 Gibson, 1996, British Thoracic Society Sarcoidosis Study; effects of long- term corticosteroid treatment, Thorax, 51, 238, 10.1136/thx.51.3.238 Takada, 1993, The clinical course and prognosis of patients with severe, moderate, or mild sarcoidosis, J Clin Epidemiol, 46, 359, 10.1016/0895-4356(93)90150-Y Gottlieb, 1997, Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy, Chest, 111, 623, 10.1378/chest.111.3.623 Mana, 2003, Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence, Sarcoidosis Vasc Diffuse Lung Dis, 20, 212 Vestbo, 1994, Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis, Sarcoidosis, 11, 123 Baughman, 1997, Predicting respiratory failure in sarcoidosis patients, Sarcoidosis Vasc Diffuse Lung Dis, 14, 154 Lewis, 2002, Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients, Sarcoidosis Vasc Diffuse Lung Dis, 19, 154 Burton, 2005, The Copenhagen National Lung Transplant Group: survival after single-lung, double-lung, and heart–lung transplantation, J Heart Lung Transplant, 24, 1834, 10.1016/j.healun.2005.03.001 Shorr, 2003, Predicting mortality in patients with sarcoidosis awaiting lung transplantation, Chest, 124, 922, 10.1378/chest.124.3.922 Gideon, 1996, Sarcoidosis mortality in the United States, 1979–1991; an analysis of multiple-cause mortality data, Am J Med, 100, 423, 10.1016/S0002-9343(97)89518-6 Yamaguchi, 1989, Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features, Sarcoidosis, 6, 138 Iwai, 1992, Morbid anatomy of sarcoidosis in Japan, Sarcoidosis, 9, 9 Perry, 1995, Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations, Arch Pathol Lab Med, 119, 167 Neville, 1983, Prognostic factors predicting the outcome of sarcoidosis. An analysis of 818 patients, Q J Med, 52, 525 Judson, 1999, Defining organ involvement in sarcoidosis: the ACCESS proposed instrument, Sarcoidosis Vasc Diffuse Lung Dis, 16, 75 Baughman, 2001, Clinical characteristics of patients in a case–control study of sarcoidosis, Am J Respir Crit Care Med, 164, 1885, 10.1164/ajrccm.164.10.2104046 Nagai, 2005, Clinical phenotypes of sarcoidosis, Japanese Journal of Sarcoidosis and Other Granulomatous Disorders, 25, 93 Judson, 2006, Comparison of sarcoidosis phenotypes among affected African American siblings, Chest, 130, 855, 10.1378/chest.130.3.855 Schischmanoff, 2006, Progressive pulmonary sarcoidosis is associated with overexpression of TYK2 and p21Wafl/Cip1, Sarcoidosis Vasc Diffuse Lung Dis, 23, 101 Rybicki, 2007, Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study, Genes Immun, 8, 379, 10.1038/sj.gene.6364396 Veltkamp, 2006, Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients, Clin Exp Immunol, 145, 215, 10.1111/j.1365-2249.2006.03127.x Berlin, 1997, HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis, Am J Respir Crit Care Med, 156, 1601, 10.1164/ajrccm.156.5.9704069 Sato, 2002, HLA-DQB ∗0201: a marker for good prognosis in British and Dutch patients with sarcoidosis, Am J Respir Cell Mol Biol, 27, 406, 10.1165/rcmb.4782 Yamaguchi, 2001, The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis, Chest, 119, 753, 10.1378/chest.119.3.753 Baughman, 2006, Pulmonary hypertension in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 108 Handa, 2006, Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis, Chest, 129, 1246, 10.1378/chest.129.5.1246 Nunes, 2006, Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics, and prognosis, Thorax, 61, 68, 10.1136/thx.2005.042838 Sulica, 2005, Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension, Chest, 128, 1483, 10.1378/chest.128.3.1483 Shigemitsu, 2007, Pulmonary hypertension and granulomatous vasculitis in sarcoidosis, Curr Opin Pulm Med, 13, 434, 10.1097/MCP.0b013e328273bc5c Shorr, 2005, Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics, Eur Respir J, 25, 783, 10.1183/09031936.05.00083404 Padia, 2007, Intravascular sarcoidosis presenting as pulmonary vein occlusion: CT and pathologic findings, J Thorac Imaging, 22, 268, 10.1097/RTI.0b013e3180437e3f Fisher, 2006, Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment, Chest, 130, 1481, 10.1378/chest.130.5.1481 Baughman, 2007, Pulmonary hypertension associated with sarcoidosis, Arthritis Res Ther, 9, s8, 10.1186/ar2192 Preston, 2001, Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension, Chest, 120, 866, 10.1378/chest.120.3.866 Johns, 1986, Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications, Ann N Y Acad Sci, 465, 702, 10.1111/j.1749-6632.1986.tb18549.x Sugisaki, 2003, Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids, Sarcoidosis Vasc Diffuse Lung Dis, 20, 222 Petinalho, 2002, Early treatment of stage II sarcoidosis improves 5-year pulmonary function, Chest, 121, 24, 10.1378/chest.121.1.24 Lower, 1995, Prolonged use of methotrexate for sarcoidosis, Arch Intern Med, 155, 846, 10.1001/archinte.155.8.846 Baughman, 2004, Leflunomide for chronic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 43 Baughman, 2006, Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement, Am J Respir Crit Care Med, 174, 795, 10.1164/rccm.200603-402OC